XLON
SMIN
Market cap10bUSD
Jun 18, Last price
2,601.00GBP
1D
0.54%
1Q
22.80%
Jan 2017
83.69%
Name
Smiths Group PLC
Chart & Performance
P/E
31.17
P/S
2.49
EPS
0.83
Div Yield, %
1.77%
Shrs. gr., 5y
-1.62%
Rev. gr., 5y
4.63%
Revenues
3.13b
+3.13%
Net income
250m
+8.23%
CFO
418m
+42.66%
Dividend
Oct 16, 202531.77 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Smiths Group plc functions as a prominent global technology company, delivering advanced solutions across a diverse range of international sectors, including medical technology, security and defense, general industrial, energy, and the space and aerospace industries. The company's operations are segmented into four specialized divisions. John Crane focuses on providing critical industrial components such as mechanical seals, seal support systems, hydrodynamic bearings, packing materials, power transmission couplings, and bespoke filtration systems. Smiths Detection is dedicated to supplying sophisticated sensors and systems capable of identifying and revealing explosives, narcotics, weapons, chemical agents, biohazards, and contraband. The Flex-Tek division manufactures precision-engineered components designed to heat and transport fluids and gases for applications in the aerospace, medical, industrial, and construction markets. Lastly, Smiths Interconnect offers a variety of highly specialized electronic and radio frequency devices, encompassing board-level and waveguide components, connectors, cables, test sockets, and integrated sub-systems, serving the security and defense, medical, general industrial, and space and aerospace markets. Established in 1851, the company was originally named Smiths Industries before rebranding as Smiths Group plc in 2000, and it is headquartered in London, United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑07 | 2023‑07 | 2022‑07 | 2021‑07 | 2020‑07 | 2019‑07 | 2018‑07 | 2017‑07 | 2016‑07 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||